方正證券(601901.SH)決定對方正和生投資增資11億元 滿足其擴大基金管理規模的業務需要
格隆匯11月29日丨方正證券(601901.SH)公佈,方正和生投資為公司全資的從事私募基金管理及相關業務的專業性證券公司私募投資基金子公司。
為滿足方正和生投資業務發展需要,公司決定對方正和生投資增資11億元,此次增資後,方正和生投資的註冊資本將由9億元增加至20億元,公司仍為其唯一股東。
此次增資符合公司戰略發展規劃,有利於增強方正和生投資的資本實力,滿足其擴大基金管理規模的業務需要,有利於方正和生投資提升市場競爭力和盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.